Our Can Ruti research community has been severely affected by the COVID-19 crisis in recent weeks. First of all, we would like to send all our sincere thanks to our colleagues in the hospital who are working with tireless professionalism to care for the unprecedented number of patients.
All the research community have responded magnificently. Although regrettably some have had to wind labs down to a minimum, everybody is contributing to fight the pandemic in one way or another.
Collaboration and strong networks have been the key to responses, with the Can Ruti community being able to take full advantage of its multidisciplinary structure to rise to the challenge. Many of our researchers have applied for grants in the emergency calls from Europe, Spain and Catalonia, some have already been awarded. The CMCiB and medical teams have worked against the clock to test not just one, but five devices to cover the deficit of ventilators in our hospitals, and three have already been approved by the AEMPS and are starting clinical trials. IrsiCaixa has brought the full force of its expertise on prevention and cure of HIV to bear on the fight against the SARS-CoV-2 virus. Several projects with teams from IDIAP Jordi Gol, also associates of our campus, have allowed us to start work on vital projects with frontline primary care healthworkers. Meanwhile, our core facilities have been working continually, despite the added difficulties, to provide essential services for all these activities.
Research projects underway include detection, prevention, diagnosis, prognosis, treatment and new therapeutics. They range from the study of the immune status of primary care workers, to the treatment of critical patients. With all of this Can Ruti and the IGTP and Germans Trias Hospital have not been out of the news during the lockdown and we are proud to be able to share some of these stories with you in this special edition of our IGTP Newsletter.
THE AEMPS has already approved 3 of the 5 ventilation devices tested by the CMCiB and medical teams
The the Autonomous Ventilation Device (DAR) is the third to receive authorization from the Spanish Agency of Medicines and Medical Devices (AEMPS) to carry out clinical trials Read more
The prototype of the RESPIRA device that mechanizes manual ressusitations with AMBU devices, providing automatic respiration assistance and monitoring, is authorized for clinical trials by the AEMPS. Read more
The OxyGEN ventilation device is authorized for clinical trials by the AEMPS. It is an emergency device that allows manual rescusitators (AMBU type) to be mechanized, so they can be used to maintain respiration autonomously. Read more
IGTP Projects at full speed
Three projects at the IGTP to study COVID-19 are underway thanks to funding received in the extraordinary call published by the Department of Health with the collaboration of AQuAS and Biocat Read more
IGTP researchers study the impact of the COVID-19 epidemic on people through in an international citizen survey. The study is being carried out using a questionnaire distributed through instant messaging and social networks to reach as many people as possible. Read more
The predictions being produced by the mathemaical model of the BIOCOMSC Group of the UPC and the CMCiB has proved an invaluable tool for national and international policy makers. It has consisently produced accurate predictions of the famous curves. Read more
Fundraising ramps up to tackle COVID-19
Fundraising is underway for vital research into all aspects of COVID-19, from testing kits to treatments, and for the innovation projects to provide the emergency ventilators so desperately needed in our hospitals. Read more
This Newsletter is for information only Please check all information on the corresponding sites
The IGTP is not responsible for the content of webpages that the user can access through links in this newsletter. The IGTP cannot examine or control the content of other sites on the web, nor can it guarantee the availability, truth, accuracy, validity or legality of sites that are not its property, but that can be accessed via links.
